Mangoceuticals (MGRX) Inventory (2023 - 2024)
Mangoceuticals (MGRX) posted Inventory of -$18501.0 for Q4 2024, down 240.02% sequentially from $13213.0 in Q3 2024, and down 200.0% YoY from $18501.0 in Q1 2024.
Mangoceuticals (MGRX) Inventory (2023 - 2024) Analysis & Trends
Mangoceuticals has reported Inventory for 2 years, with the latest figure at -$18501.0 in Q4 2024.
- Quarterly Inventory fell 200.0% year-over-year to -$18501.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$18501.0 (down 200.0% YoY) and the FY2024 annual result came in at -$18501.0, down 200.0% from the prior year.
- Inventory declined to -$18501.0 in Q4 2024 per MGRX's latest filing, from $13213.0 in the prior quarter.
- Over five years, Inventory peaked at $23494.0 in Q2 2023 and troughed at -$18501.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 575.01 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | - |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 52.62 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 16.77 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 341.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | - |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Mangoceuticals | 9.55 Mn | 9.30 Mn | 44,215.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -18,501.00 |
| Sep 30, 2024 | 13,213.00 |
| Jun 30, 2024 | 14,019.00 |
| Mar 31, 2024 | 14,452.00 |
| Dec 31, 2023 | 18,501.00 |
| Sep 30, 2023 | 21,581.00 |
| Jun 30, 2023 | 23,494.00 |